RE
Replimune
REPL·NASDAQWoburn MAFounded 2015250 employees
Small CapbiotechPublicOncology
Platform: Oncolytic
Market Cap
$1.2B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (REPL)
Loading REPL stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| REP-2935 | REP-2935 | Approved | 2 | CD20 | OCD | ||
| Olpavorutinib | REP-9851 | Phase 2 | 1 | Tau | Pancreatic CaPSP |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)